Novartis announces new organizational structure to accelerate growth, strengthen pipeline and increase productivityGlobeNewsWire • 04/04/22
Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in EuropeGlobeNewsWire • 03/25/22
Novartis' (NVS) Pluvicto Gets FDA Nod for Advanced Prostate CancerZacks Investment Research • 03/24/22
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy StudyBenzinga • 03/14/22
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protectionGlobeNewsWire • 03/13/22
Voyager Therapeutics Shares Jump On Novartis Option Agreement For Gene Therapy ProgramsBenzinga • 03/08/22
Novartis Is One Of The Best High-Yield Dividend Aristocrats You Can Buy In 2022Seeking Alpha • 02/18/22
Molecular Partners, Novartis Submit Emergency Use Authorization Request For Ensovibep For COVID-19Benzinga • 02/10/22
Novartis AG (NVS) CEO Vasant Narasimhan on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/02/22